MDBZ, or 3,4-methylenedioxy-N-benzylamphetamine, is a lesser-known psychedelic drug. It is the N-benzyl derivative of MDA. MDBZ was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 150mg, and the duration unknown. MDBZ produces few to no effects. Very few data exist about the pharmacological properties, metabolism, and toxicity of MDBZ.

CAS：65033-29-6
中文别名：
英文别名：(2-benzo[1,3]dioxol-5-yl-1-methyl-ethyl)-benzyl-amine;N-Benzyl-3,4-methylenedioxyamphetamine;Methylenedioxybenzylamphetamine;
分子式：C17H19NO2
分子量：269.338
精确质量：269.142
Psa：30.49
Logp：3.527

UNII：QR8242661A